During the past decade, Drug Studies America conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 32 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 16 clinical trials were completed. i.e. 177.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Drug Studies America" #1 sponsor was "Pfizer" with 9 trials, followed by "BioDelivery Sciences International" with 3 trials sponsored, "AEON Biopharma, Inc." with 2 trials sponsored, "Ampio Pharmaceuticals. Inc." with 2 trials sponsored and "Cephalon" with 2 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Drug Studies America" #1 collaborator was "PPD" with 2 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Drug Studies America" are "Low Back Pain" (8 trials), "Chronic Pain" (7 trials), "Osteoarthritis" (6 trials), "Osteoarthritis, Knee" (5 trials) and "Pain" (4 trials). Many other conditions were trialed in "Drug Studies America" in a lesser frequency.

Most popular intervention types in "Drug Studies America" are "Drug" (45 trials), "Biological" (8 trials), "Other" (8 trials), "Device" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Diclofenac" (3 trials), "Naproxen" (3 trials), "ABP-450" (2 trials) and "Buprenorphine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Drug Studies America" are 52 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Drug Studies America". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in Drug Studies America, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Drug Studies America, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".